Increasing applicability of liver transplantation for patients with hepatitis B-related liver disease

Samuel, 1993, Liver transplantation in European patients with the hepatitis B surface antigen, N Engl J Med, 329, 1842, 10.1056/NEJM199312163292503 König, 1994, Long-term follow up of hepatitis B virus-infected recipients after orthotopic liver transplantation, Transplantation, 58, 553, 10.1097/00007890-199409150-00005 Samuel, 1991, Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients, Lancet, 337, 813, 10.1016/0140-6736(91)92515-4 Devlin, 1994, Impact of immunoprophylaxis and patient selection on outcome of transplantation for HBsAg-positive liver recipients, J Hepatol, 21, 204, 10.1016/S0168-8278(05)80396-4 Sawyer, 1998, Improved clinical outcomes with liver transplantation for hepatitis B-induced chronic liver failure using passive immunization, Ann Surg, 227, 841, 10.1097/00000658-199806000-00007 Protzer-Knolle, 1998, Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation, Hepatology, 27, 254, 10.1002/hep.510270138 Terrault, 1998, Incidence and clinical consequences of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulin, Hepatology, 28, 555, 10.1002/hep.510280237 Mutimer, 1999, Long term outcome of liver transplantation for viral hepatitis: is there need to re-evaluate patient selection?, Gut, 45, 475, 10.1136/gut.45.4.475 Muller, 1994, ‘EUROHEP’ consensus report on the management of liver transplantation for hepatitis B virus infection. European Concerted Action on Viral Hepatitis, J Hepatol, 21, 1140, 10.1016/S0168-8278(05)80632-4 Wiesner, 1995, Liver transplantation for hepatitis B: the con aspect, Liver Transplant Surg, 1, 265, 10.1002/lt.500010415 Kruger, 1996, Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: a pilot study, Liver Transpl Surg, 2, 253, 10.1002/lt.500020402 Rayes, 1999, Long term results of famciclovir for recurrent or de novo hepatitis B virus infection after liver transplantation, Clin Transplantation, 13, 447, 10.1034/j.1399-0012.1999.130602.x Nery, 1998, Efficacy of lamivudine in controlling hepatitis B virus recurrence after liver transplantation, Transplantation, 65, 1615, 10.1097/00007890-199806270-00013 Perrillo, 1999, Multicenter study of lamivudine therapy for hepatitis B after liver transplantation, Hepatology, 29, 1581, 10.1002/hep.510290507 Perrillo, 2000, Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants, Hepatology, 32, 129, 10.1053/jhep.2000.8626 Seehofer, 2000, Lamivudine as first and second line treatment of hepatitis B infection after liver transplantation, Transplant Int, 13, 290, 10.1111/j.1432-2277.2000.tb01084.x Seehofer, 2000, Additional interferon alpha for lamivudine resistant hepatitis B infection after liver transplantation: a preliminary report, Transplantation, 69, 1739, 10.1097/00007890-200004270-00039 Lok, 2001, Chronic hepatitis B, Hepatology, 34, 1225, 10.1053/jhep.2001.29401 Lemmens, 1994, Outcome following orthotopic liver transplantation in HBsAg-positive patients using short- or long-term immunoprophylaxis, Transplant Proc, 26, 3622 Lerut, 1999, Liver transplantation and HBsAg positive postnecrotic cirrhosis: adequate immunoprophylaxis and delta virus co-infection as the significant determinants of long-term prognosis, J Hepatol, 30, 706, 10.1016/S0168-8278(99)80203-7 Samuel, 1995, Long-term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis, Hepatology, 21, 333, 10.1002/hep.1840210211 Huang, 1996, Hepatitis B and C coinfections and persistent hepatitis B infections: clinical outcome and liver pathology after transplantation, Hepatology, 23, 396, 10.1002/hep.510230302 Gish, 1995, Survival after liver transplantation for chronic hepatitis B using reduced immunosuppression, J Hepatol, 22, 257, 10.1016/0168-8278(95)80276-2 Tschevenkov, 1997, Recurrence free long-term survival after liver transplantation for hepatitis B using interferon-alphy pretransplant and hepatitis B immune globulin posttransplant, Ann Surg, 226, 356, 10.1097/00000658-199709000-00015 Markowitz, 1998, Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin, Hepatology, 28, 585, 10.1002/hep.510280241 Yoshida, 1999, Liver transplantation for chronic hepatitis B infection with the use of combination lamivudine and low-dose hepatitis B immune globulin, Liver Transpl Surg, 5, 520, 10.1002/lt.500050602 Seehofer, 2001, Preoperative antiviral treatment and postoperative prophylaxis in HBV-DNA positive patients undergoing liver transplantation, Transplantation, 72, 1381, 10.1097/00007890-200110270-00008 Mutimer, 1999, High pre-treatment serum hepatitis B virus titre predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation, J Hepatol, 30, 715, 10.1016/S0168-8278(99)80204-9 Shields, 1999, Selection of hepatitis B surface “escape” mutants during passive immune prophylaxis following liver transplantation: potential impact of genetic changes on polymerase protein function, Gut, 45, 306, 10.1136/gut.45.2.306 Sanchez Fueyo, 2000, Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: a new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation, Hepatology, 31, 496, 10.1002/hep.510310233 Lo, 2001, Liver transplantation in Asian patients with chronic hepatitis B using lamivudine prophylaxis, Ann Surg, 233, 276, 10.1097/00000658-200102000-00018 Todo, 1991, Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease, Hepatology, 13, 619 Naumann, 1997, Pretransplant infection with precore mutants of hepatitis B virus does not influence the outcome of orthotopic liver transplantation in patients on high dose anti-hepatitis B virus surface antigen immunoprophylaxis, Hepatology, 26, 478, 10.1002/hep.510260232 Angus, 1995, Hepatitis B virus precore mutant infection is associated with severe recurrent disease after liver transplantation, Hepatology, 21, 14, 10.1002/hep.1840210104 Bain, 1996, Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation, Transplantation, 62, 1456, 10.1097/00007890-199611270-00013 Ben-Ari, 1997, Beneficial effect of lamivudine pre- and post-liver transplantation for hepatitis B infection, Transplant Proc, 29, 2687, 10.1016/S0041-1345(97)00556-3 McCaughan, 1999, Lamivudine therapy in patients undergoing liver transplantation for hepatitis B virus precore mutant-associated infection: high resistance rates in treatment of recurrence but universal prevention if used as prophylaxis with very low dose hepatitis B immune globulin, Liver Transplant Surg, 5, 512, 10.1002/lt.500050601 Bartholomew, 1997, Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation, Lancet, 349, 20, 10.1016/S0140-6736(96)02266-0 de-Man, 1998, The sequential occurrence of viral mutations in a liver transplant recipient re-infected with hepatitis B: hepatitis B immune globulin escape, famciclovir non-response, followed by lamivudine resistance resulting in graft loss, J Hepatol, 29, 669, 10.1016/S0168-8278(98)80164-5 Locarnini, 1999, Antiviral chemotherapy for chronic hepatitis B infection: lessons learned from treating HIV-infected patients, J Hepatol, 30, 536, 10.1016/S0168-8278(99)80118-4 Honkoop, 1997, Lamivudine resistance in immunocompetent chronic hepatitis B. Incidence and patterns, J Hepatol, 26, 1393, 10.1016/S0168-8278(97)80476-X Mutimer, 2000, Outcome of lamivudine resistant hepatitis B virus infection in the liver transplant recipient, Gut, 46, 107, 10.1136/gut.46.1.107 Seehofer, 2001, Occurrence and clinical outcome of lamivudine resistant hepatitis B infection after liver transplantation, Liver Transpl, 7, 976, 10.1053/jlts.2001.28442 Villeneuve, 2000, Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B, Hepatology, 31, 207, 10.1002/hep.510310130 Kitay Cohen, 2000, Extension of transplantation free time by lamivudine in patients with hepatitis B-induced decompensated cirrhosis, Transplantation, 69, 2382, 10.1097/00007890-200006150-00028